Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes

Clinical Science

Volumn 123, Issue 8, 2012, Pages 519-529

  Tikellis, Chris ^a   Pickering, Raelene ^a   Tsorotes, Despina ^a   Du, Xiao Jun ^a   Kiriazis, Helen ^a   Nguyen Huu, Thu Phuc ^a   Head, Geoffrey A ^a   Cooper, Mark E ^a   Thomas, Merlin C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angiotensin; Angiotensin converting enzyme 2; Diabetes; Diabetic cardiomyopathy; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CELL ADHESION MOLECULE; CHYMASE; CONNECTIVE TISSUE GROWTH FACTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL COLLAGENASE; OSTEOPONTIN; RAS PROTEIN; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANGIOTENSIN II; AUTACOID; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; APOPTOSIS; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; M MODE ECHOCARDIOGRAPHY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TELEMETRY; TUNEL ASSAY; UPREGULATION; ANIMAL; AORTA DISEASE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; C57BL MOUSE; DIABETIC ANGIOPATHY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; AORTIC DISEASES; APOPTOSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; PLAQUE, ATHEROSCLEROTIC; TELEMETRY;

EID: 84866466550     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110668     Document Type: Article

References (41)

1. Groop, P.H., Thomas, M.C., Moran, J.L., Waden, J., Thorn, L.M., Makinen, V.P., Rosengard-Barlund, M., Saraheimo, M., Hietala, K., Heikkila, O. et al. (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58, 1651-1658.
2. Aneja, A., Tang, W.H., Bansilal, S., Garcia, M.J. and Farkouh, M.E. (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am. J. Med. 121, 748-757.
3. Boudina, S. and Abel, E.D. (2007) Diabetic cardiomyopathy revisited. Circulation 115, 3213-3223.
4. Fang, Z.Y., Prins, J.B. and Marwick, T.H. (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25, 543-567.
5. Candido, R., Allen, T.J., Lassila, M., Cao, Z., Thallas, V., Cooper, M.E. and Jandeleit-Dahm, K.A. (2004) Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109, 1536-1542.
6. Daugherty, A., Manning, M.W. and Cassis, L.A. (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605-1612.
7. Ferrario, C.M. and Strawn, W.B. (2006) Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am. J. Cardiol. 98, 121-128.
8. Ekholm, M., Kahan, T., Jorneskog, G., Broijersen, A. and Wallen, N.H. (2009) Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo. Thromb. Res. 124, 110-115.
9. Candido, R., Jandeleit-Dahm, K.A., Cao, Z., Nesteroff, S.P., Burns, W.C., Twigg, S.M., Dilley, R.J., Cooper, M.E. and Allen, T.J. (2002) Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106, 246-253.
10. Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B. and Anversa, P. (2000) Myocardial cell death in human diabetes. Circ. Res. 87, 1123-1132.
11. Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E.H., Anversa, P., Leri, A. and Kajstura, J. (2000) Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest. 80, 513-527.
12. Knowles, J.W., Reddick, R.L., Jennette, J.C., Shesely, E.G., Smithies, O. and Maeda, N. (2000) Enhanced atherosclerosis and kidney dysfunction in eNOS-/- Apoe-/- mice are ameliorated by enalapril treatment. J. Clin. Invest. 105, 451-458.
13. Garabelli, P.J., Modrall, J.G., Penninger, J.M., Ferrario, C.M. and Chappell, M.C. (2008) Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp. Physiol. 93, 613-621.
14. Stewart, Jr, J.A., Lazartigues, E. and Lucchesi, P.A. (2008) The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication? Circ. Res. 103, 1197-1199.
15. Crackower, M.A., Sarao, R., Oudit, G.Y., Yagil, C., Kozieradzki, I., Scanga, S.E., Oliveira-dos-Santos, A.J., da Costa, J., Zhang, L., Pei, Y. et al. (2002) Angiotensinconverting enzyme 2 is an essential regulator of heart function. Nature 417, 822-828.
16. Nakamura, K., Koibuchi, N., Nishimatsu, H., Higashikuni, Y., Hirata, Y., Kugiyama, K., Nagai, R. and Sata, M. (2008) Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice. Hypertens. Res. 31, 1953-1961.
17. Bernardi, S., Burns, W.C., Toffoli, B., Pickering, R., Sakoda, M., Tsorotes, D., Grixti, E., Velkoska, E., Burrell, L.M., Johnston, C. et al. (2012) Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7). Clin. Sci. 123, 29-37.
18. Thomas, M.C., Pickering, R.J., Tsorotes, D., Koitka, A., Sheehy, K., Bernardi, S., Toffoli, B., Nguyen-Huu, T.P., Head, G.A., Fu, Y. et al. (2010) Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ. Res. 107, 888-897.
19. Tikellis, C., Johnston, C.I., Forbes, J.M., Burns, W.C., Thomas, M.C., Lew, R.A., Yarski,M., Smith, A.I. and Cooper, M.E. (2004) Identification of angiotensin converting enzyme 2 in the rodent retina. Curr. Eye Res. 29, 419-427.
20. Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Su, Q., Johnston, C., Cooper, M. and Thomas, M. (2008) ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57, 1018-1025.
21. Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Su, Q., Johnston, C., Cooper, M.E. and Thomas, M.C. (2008) ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57, 1018-1025.
22. Gurley, S.B., Allred, A., Le, T.H., Griffiths, R., Mao, L., Philip, N., Haystead, T.A., Donoghue, M., Breitbart, R.E., Acton, S.L. et al. (2006) Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Invest. 116, 2218-2225.
23. Oudit, G.Y., Kassiri, Z., Patel, M.P., Chappell, M., Butany, J., Backx, P.H., Tsushima, R.G., Scholey, J.W., Khokha, R. and Penninger, J.M. (2007) Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc. Res. 75, 29-39.
24. Jackson, K., Head, G.A., Morris, B.J., Chin-Dusting, J., Jones, E., La Greca, L. and Mayorov, D.N. (2007) Reduced cardiovascular reactivity to stress but not feeding in renin enhancer knockout mice. Am. J. Hypertens. 20, 893-899.
25. Du, X.J., Samuel,C. S., Gao, X.M., Zhao, L., Parry, L.J. and Tregear, G.W. (2003) Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc. Res. 57, 395-404.
26. Tan, T.P., Gao, X. -M., Krawczyszyn,M., Feng,X., Kiriazis, H., Dart, A.M. and Du, X. -J. (2003) Assessment of cardiac function by echocardiography in conscious and anesthetized mice: importance of the autonomic nervous system and disease state. J. Cardiovasc. Pharmacol. 42, 182-190.
27. Thomas, M.C., Tikellis, C., Burns, W.M., Bialkowski, K., Cao, Z., Coughlan, M.T., Jandeleit-Dahm, K., Cooper, M.E. and Forbes, J.M. (2005) Interactions between renin angiotensin system and advanced glycation in the kidney. J. Am. Soc. Nephrol. 16, 2976-2984.
28. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9.
29. Matsui, Y., Jia, N., Okamoto, H., Kon, S., Onozuka, H., Akino, M., Liu, L., Morimoto, J., Rittling, S.R., Denhardt, D. et al. (2004) Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 43, 1195-1201.
30. Candido, R., Forbes, J.M., Thomas, M.C., Thallas, V., Dean, R.G., Burns, W.C., Tikellis, C., Ritchie, R.H., Twigg, S.M., Cooper, M.E. et al. (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 92, 785-792.
31. Wei,C.C., Tian, B., Perry, G.,Meng, Q.C.,Chen, Y.F., Oparil, S. and Dell'Italia, L.J. (2002) Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am. J. Physiol. Heart Circ. Physiol. 282, H2254-H2258.
32. Liu, X., Suzuki, H., Sethi, R., Tappia, P.S., Takeda, N. and Dhalla, N.S. (2006) Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes. Ann. N.Y. Acad. Sci. 1084, 141-154.
33. McCollum, L.T., Gallagher, P.E. and Ann Tallant, E. (2012) Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. Am. J. Physiol. Heart Circ. Physiol. 302, H801-H810.
34. Trask, A.J. and Ferrario, C.M. (2007) Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments. Cardiovasc. Drug Rev. 25, 162-174.
35. Benter, I.F., Yousif, M.H., Cojocel, C., Al-Maghrebi, M. and Diz, D.I. (2007) Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am. J. Physiol. Heart Circ. Physiol. 292, H666-H672.
36. Tesanovic, S., Vinh, A., Gaspari, T.A., Casley, D. and Widdop, R.E. (2010) Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 30, 1606-1613.
37. Santos, R.A., Simoes e Silva, A.C., Maric, C., Silva, D.M., Machado, R.P., de Buhr, I., Heringer-Walther, S., Pinheiro, S.V., Lopes, M.T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263.
38. Tallant, E.A., Ferrario, C.M. and Gallagher, P.E. (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the Mas receptor. Am. J. Physiol. Heart Circ. Physiol. 289, H1560-H1566.
39. Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C.F., Heringer-Walther, S., Sexton, P.M., Gembardt, F., Kellett, E., Martini, L. et al. (2005) G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806-1813.
40. Laxton, R.C., Hu, Y., Duchene, J., Zhang, F., Zhang, Z., Leung, K.Y., Xiao, Q., Scotland, R.S., Hodgkinson, C.P., Smith, K. et al. (2009) A role of matrix metalloproteinase-8 in atherosclerosis. Circ. Res. 105, 921-929.
41. Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P.C., Levitt, K.S., Oudit, G.Y., Al-Omran, M. et al. (2008) Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 295, H1377-H1384.